ProCE Banner Activity

Key Data From SABCS 2020: A European Perspective

Conference Coverage
Clinical Thought
Get a quick European perspective on key studies from the 2020 breast cancer meeting

Released: March 08, 2021

Expiration: March 07, 2022

Share

Faculty

Javier Cortes

Javier Cortes, MD, PhD

Head, Breast Cancer Program
IOB Institute of Oncology
Madrid and Barcelona, Spain

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Javier Cortes, MD, PhD

Head, Breast Cancer Program
IOB Institute of Oncology
Madrid and Barcelona, Spain

Javier Cortes, MD, PhD, has disclosed that he has received funds for research support (paid to his institution) from Ariad, AstraZeneca, Baxalta GMBH/Servier Affaires, Bayer, Eisai, F. Hoffmann-La Roche, Guardant Health, Merck Sharp & Dohme, Pfizer, Piqur Therapeutics, Puma, Roche, and Queen Mary University of London and consulting fees from AstraZeneca, Athenex, Bioasis, Biothera, Celgene, Cellestia, Clovis Oncology, Daiichi Sankyo, Erytech, GlaxoSmithKline, Leuko, Lilly, MedSIR, Merck Sharp & Dohme, Merus, Polyphor, Roche, Seattle Genetics, and Servier.